Source: BioSpace

Modis Therapeutics: EdiGENE Changes Name to Modalis Therapeutics

EdiGENE Corporation announced that the company has changed its name to Modalis Therapeutics Corporation.

Read full article »
Modis Therapeutics's Competitors | Modis Therapeutics's News | Modis Therapeutics's Financials
Stay up-to-date with the latest news on Modis Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Joshua Grass's photo - CEO of Modis Therapeutics

CEO

Joshua Grass

CEO Approval Rating

86/100

Read more
Stay up-to-date with the latest news on Modis Therapeutics